Research and Development

Summer seems to be in full swing as we reach the end of June, so it’s time to look back …

A new formulation of a drug to prevent excessive bleeding in women after childbirth could save thousands of lives, says …

Advancement of IT within healthcare is transforming the dynamics of the patient-physician relationship and it is important to integrate various …

Summit Therapeutics has revealed it is to terminate development of its Duchenne muscular dystrophy (DMD) drug ezutromid after it failed …

Amgen has unveiled new Phase 3 data for its biosimilar version of Johnson & Johnson’s Remicade (infliximab), confirming that it …

Minneapolis-based hospital Hennepin County Medical Center has put the brakes on a clinical trial investigating the efficacy of ketamine in …

The partnership of Abbvie and Google’s Calico has announced they are to extend their existing 10-year drug discovery and development …

AstraZeneca is celebrating alongside partner MSD with the reveal of new data on the use of Lynparza in the first-line …

Drug development firm Pain Therapeutics has revealed that its abuse-deterrent opioid medication Remoxy has been rejected by an FDA advisory …

Roivant, the global biopharmaceutical firm spearheaded by founder and CEO Vivek Ramaswamy (pictured), has announced it is to undergo a …

Pfizer has stumbled with the reveal of new data on the efficacy of its oral CDK 4/6 inhibitor Ibrance (palbociclib) in combination …

Sanofi took the opportunity at the American Diabetes Association (ADA) 78th Scientific Sessions in Florida to unveil new data on …

Pharmafocus caught up with Vertex Pharma’s Simon Lem to discuss his journey throughout the industry and the importance of the …

Another clinical trial has been forced to a standstill as biotech firm Sophiris revealed that a patient death had prompted …

Eli Lilly has announced new data on its once-weekly, injectable glucagon-like peptide Trulicity (dulaglutide 1.5mg) and investigational 3.0 and 4.5mg …